Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • The cover letter has been provided
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Atomic Layer Deposition International Journal  (ALDJ) focuses on scientific aspects of atomic/molecular layer deposition, vapor phase infiltration, atomic layer etching and related methods. All manuscripts should make a significant contribution to the field. Both experimental and theoretical work is welcomed.

You can submit an article using our Open Journal System (OJS) link (please register on the manuscript submission website after clicking). In addition, please send a copy of your manuscript (and cover letter) by email to editorial@atomiclayerdeposition.com.

All submitted manuscripts should clearly highlight areas of their significance and the impact of these in addressing current and outstanding issues in the field.

1. Manuscript Content

ALDJ publishes articles in the following areas:

  • Atomic Layer Deposition (ALD)
  • Molecular Layer Deposition (MLD)
  • Alternating Vapor Infiltration / Vapor Phase Infiltration (VPI)
  • Atomic Layer Etching (ALE)
  • General science or new concepts concomitant to the above areas

and their relation to:

  • Precursor chemistry
  • Reaction chemistry
  • Theoretical chemistry
  • Growth, surface and film analysis
  • Reactor technology
  • Applications

2. Manuscript Type

Text should be single-spaced and free of all corrections. Please submit both an editable document (Word, LaTeX etc) as well as a PDF file. Figures should be separate from the text; each figure should be presented on a separate A4 sheet. Manuscript should not contain author names (for the blind peer review process).

3. Cover Letter

You should add a (PDF) cover letter with details of the authors, including affiliations and e-mail addresses. You may also suggest peer reviewers well familiar with the subject of your manuscript. 

4. Manuscript Categories

(1) Original Articles

This is the most common type of journal manuscript used to publish full reports of data from research. It may be called an Original Article, Research Article, Research, or just Article, depending on the journal. It includes full Introduction, Methods, Results, and Discussion sections.

Word limit: 5,000 words maximum including abstract but excluding references, tables and figures.

Abstract: 350 words maximum, structured with the following subheadings: Background, Methods, Results and Conclusions.

References: There is no limit on the number of references that can be included.

Figures/Tables: There is no limit on the number of figures and tables that can be included, however we recommend 5 figures/ tables per article is most appropriate.

Description: Full-length reports of current research in either basic or clinical science. Meta-analysis will be categorized into “original articles”.

(2) Reviews

Review articles should contain authors’ analytical appraisal of published papers and personal viewpoints, instead of a mere aggregation of published abstracts. Review Articles provide a comprehensive description of research on a certain topic, and a perspective on the state of the field and where it is heading. They are often written by leaders in a particular discipline after invitation from the editors of a journal. Reviews are often widely read (for example, by researchers looking for a full introduction to a field) and highly cited. Reviews commonly cite approximately 100 primary research articles.

Word limit: no limit.

Abstract: 400 words maximum.

References: There is no limit on the number of references that can be included.

Figures/Tables: There is no limit on the number of figures and tables that can be included.

Description: Review articles should contain authors’ analytical appraisal of published papers and personal viewpoints, instead of a mere aggregation of published abstracts.

(3) Mini Reviews (Research Highlights)

Mini Reviews are shorter reviews of topics that may be controversial or unresolved.

Word limit: 5,000 words maximum including abstract but excluding references, tables and figures.

Abstract: 400 words maximum.

References: There is no limit on the number of references that can be included.

Figures/Tables: There is no limit on the number of figures and tables that can be included.

Description: Mini Reviews are shorter reviews of topics that may be controversial or unresolved.

(4) Letters to the Editor

Letters usually offer perspective to content published in this journal. In this case, a Letter must refer to the original source, and a Response to a Letter must reference the Letter in the first few paragraphs. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion. Presentation of interesting clinical cases can also be published in this format. Letters of any matter of interest to readers of the journal are also published.

Word limit: 1000 words maximum excluding references, tables and figures.

Abstract: not required for this manuscript type.

References: 10 references maximum can be included in Letters to the Editor articles.

Figures/Tables: 1 figure or table maximum can be included in Letters to the Editor articles.

Description: Letters to the Editor usually offer perspective to content published in this journal. In this case, a Letter must refer to the original source, and a Response to a Letter must reference the Letter in the first few paragraphs. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion. Presentation of interesting clinical cases can also be published in this format. Letters of any matter of interest to readers of the journal are also published.

(5) Editorials

Editorials will be written by the recognized leader(s) or experts in their field.

Word Limit: 2,500 words maximum excluding references, tables and figures.

Abstract: Not required.

References: 25 references maximum can be included in editorial articles.

Figures/Tables: 2 figures or tables maximum can be included in editorial articles.

Description: Editorial is written by the recognized leader(s) or experts in the field.

(6) Editorial Commentaries

Subject experts will be invited to discuss recent papers, reports or events to provide a commentary on their importance. Editorial commentaries will set the problems addressed by the paper/ report/event in the wider context of the topic.

Word Limit: 2,500 words maximum excluding references, tables and figures.

Abstract: not required.

References: 25 references maximum can be included in editorial commentary articles.

Figures/Tables: 2 figures or tables maximum can be included in editorial commentary articles.

Description: Subject experts will be invited to discuss recent papers, reports or events to provide a commentary on their importance. Editorial commentaries will set the problems addressed by the paper/ report/event in the wider context of the topic.

(7) Perspectives/Opinions

Perspectives can be more personal, forward-looking or speculative, compared with reviews of a scientific topic. A paper presenting controversial positions or papers of the same topic advocate opposite sides will be published as a perspective. While perspectives will be solicited by the editors; we also welcome timely, unsolicited perspectives.

Word limit: 3000 words maximum including abstract but excluding references, tables and figures.

Abstract: Unstructured. 300 words maximum.

References: There is no limit on the number of references that can be included.

Figures/Tables: 2 figures or tables maximum can be included in editorial commentary articles.

Description: Perspectives can be more personal, forward-looking or speculative, compared with reviews of a scientific topic. A paper presenting controversial positions or papers of the same topic advocate opposite sides will be published as a perspective. While perspectives will be solicited by the editors; we also welcome timely, unsolicited perspectives.

(8) Case Reports

New observations of chemistry related to ALD, MLD, ALE. Only cases of exceptional interest and novelty are considered. These articles report specific instances of interesting phenomena. A goal of Case Studies is to make other researchers aware of the possibility that a specific phenomenon might occur. This type of study is often used in medicine to report the occurrence of previously unknown or emerging pathologies.

Word limit: 2,500 words maximum excluding references, tables and figures.

Abstract: A brief abstract, usually of 3-4 sentences, is required.

Figures/Tables: 8 figures or tables maximum can be included in case report articles.

Description: New observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in medicine. The text should be arranged as follows: Introduction, Case Report, Discussion. We do not publish case report only because of the rarity of the cases. Only cases of exceptional interest and novelty are considered. For manuscripts that do not qualify, Editors may ask authors to shorten manuscripts and rewrite as Letters to the Editor.

(9) Technical Notes

Technical notes articles should present a new experimental or improved method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well-tested and ideally, but not necessarily, used in a way that proves its value.

Word limit: 2,500 words including abstract but excluding references, tables and figures.

Abstract: 250 words, unstructured (no sub-headers).

References: 35 references maximum can be included in editorial articles.

Figures/Tables: 10 figures or tables maximum can be included in editorial articles.

Description: Technical notes articles should present a new experimental or improved method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well-tested and ideally, but not necessarily, used in a way that proves its value.

(10) Brief Reports

Manuscripts containing pertinent and interesting observations concerning relevant research in the field of biomedicine and reports on new observations or studies that do not warrant publication as a full research article will be considered for the Brief Reports. These submissions will undergo full peer review.

Word limit: 2,500 words including abstract but excluding references, tables and figures.

Abstract: 250 words, unstructured (no sub-headers).

References: 350 words maximum.

Figures/Tables: 8 figures or tables maximum can be included in editorial articles.

Description: Manuscripts containing pertinent and interesting observations concerning relevant research in the field of biomedicine and reports on new observations or studies that do not warrant publication as a full research article will be considered for the Brief Reports. These submissions will undergo full peer review.

(11). News and views

Publishes the latest news and views regarding “hot topics”, issues which have global impacts, special and rare issues or summaries of recent events involving BIO Integration.

Word limit: None

Abstract: Not applicable

References: There is no limit on the number of references that can be included.

Figures/Tables: There is no limit on the number of figures and tables that can be included.

Description: News and views are usually invitational, highlighting recent scientific/medical breakthroughs. This category can also be used to highlight recent events regarding BIO Integration.

(12). Commentary

Publishes expert opinions regarding a recent impactful publications, with special emphasis on integrative science publications.

Word limit: None

Abstract: Not applicable

References: There is no limit on the number of references that can be included.

Figures/Tables: There is no limit on the number of figures and tables that can be included.

Description: Publishes expert opinions regarding a recent impactful publication, with special emphasis on integrative scientific publications.

Articles

Section default policy

Copyright Notice

ALDiJ guarantees that all published material will be available for perpetuity. ALDiJ is a subscriber member to the Portico digital preservation service provided by ITHAKA, a not-for-profit organization with a mission to help the academic community use digital technologies to preserve the scholarly record and to advance research and teaching in sustainable ways.

Portico acts as an independent back up repository for publishers’ online content. Membership of Portico demonstrates a publisher’s commitment to ensuring that valuable material they have published will always be available independent of the publisher’s own existence.

What Portico does:

Portico provides access to its library participants when specific conditions or “trigger events” occur, which may cause journal titles to no longer be available from the publisher or any other source such as:

  • When a publisher ceases operations and titles are no longer available from any other source
  • When a publisher ceases to publish and offer a title, and it is not offered by another publisher or entity
  • When back issues are removed from a publisher’s offering and are not available elsewhere
  • Upon catastrophic failure by a publisher’s delivery platform for a sustained period of time

When e-journal titles have “triggered,” they are available to all participants in the Portico E-Journal Preservation Service, regardless of whether the participating institution has previously licensed the content.

Privacy Statement

In keeping with EU General Data Protection Regulation (GDPR) our privacy policy provides details on:

  • The information that we collect;
  • How we use this information, why we store and why we retain it;
  • How you can request that your information is updated, corrected, or deleted.

Your Rights

Per the General Data Protection Regulations 2018, you have the following rights:

  • The right to be informed
  • A right of access – you have the right to access the information we hold about you. This is called a subject access request and must be made to using the e-mail address set out below.
  • The right of rectification – should you feel that we hold incorrect or incomplete information about you, please contact sales@compuscript.com to amend/update the data as desired.
  • The right of erasure (right to be forgotten) – please see the section on right to erasure.
  • The right of data portability
  • The right to restrict processing – we will always respect a request by you to stop contact by any or all methods of communication or for any specific purpose.
  • The right to object – we are registered with the data commissioner’s office and it is your right to lodge a complaint with them.

About Us

As the operators of the ALDiJ website, we are committed to protecting and respecting your privacy. This Privacy Policy sets out the basis on which the personal data collected from you or provided by you will be processed by us. Please read the following carefully to understand our views and practices regarding your personal data and how we will treat it.

For the purpose of the General Data Protection Regulations 2016, the Data Protection Appointed person is Teresa Nolan, Compuscript Limited, Shannon Industrial Estate, Shannon, Co. Clare.

We follow the following principles to protect your privacy and to comply with GDPR:

  • We do not collect more information than is necessary
  • We do not use your data for purposes other than those specified
  • We do not keep your data if it is no longer needed
  • We do not share your data with third parties
  • We use the appropriate technical measures to ensure that your data is securely stored on our system

Why we collect personal data

We collect data so that we may provide you with a reliable and efficient service which enables us to publish Atomic Layer Deposition journal and to carry out our obligations arising from any contracts entered between you and us. We also collect data so that you can be kept informed of all relevant developments concerning the Atomic Layer Deposition journal.

Cookies

Cookies are used to collect information about how visitors use our website, for example, which pages visitors go to most often. These cookies do not collect information that identifies a visitor.

All information these cookies collect is aggregated and is therefore anonymous. It is only used to compile reports to help us improve our website. Information collected by these cookies cannot tract your browsing activity on other websites

Other third-party sources of data

If collecting information from a third party, we will seek your consent in advance or otherwise make you aware of the collection and the reasons for it.

Where your data is stored

Your data will be stored within our database. This system is cloud based, but we ensure that all necessary data protection protocols are in place.

Sensitive data

We do not store any sensitive personal data (as defined in the General Data Protection Regulation 2016 Article 9), unless it has been provided by you as a part of the application or screening process. In this case it will only be stored with your specific consent.

Right to erasure

If you exercise your right to erasure, we will retain all that information which we are legally obligated to retain (such as employment contract data or financial payment), for the period that is set out by that legal obligation. We may also keep your name and the bare minimum of contact details so that we do not contact you or re-enter your details inadvertently in the future.

Mode and place of processing the data

At Atomic Layer Deposition we take appropriate security measures to prevent unauthorised access, disclosure, modification, or unauthorised destruction of the data.

The data processing is carried out using computers and/or IT-enabled tools, following organisational procedures and modes strictly related to the purposes indicated. In some cases, the data may be accessible to certain types of persons in charge, involved with the operation of the site (administration, legal, system administration) or external parties (such as third-party technical service providers, mail carriers, hosting providers, IT companies, communications agencies) appointed, if necessary, as Data Processors by the owner. The updated list of these parties may be requested from the Data Controller at any time.

Retention Period

The data is kept for the time necessary to provide the service requested by the user, or stated by the purposes outlined in this document, and the user can always request that the Data Controller suspend or remove the data. Please contact sales@compuscript.com in this regard.

Additional information about data collection and processing

The rights of Users

Users have the right, at any time, to know whether their personal data has been stored and can consult the Data Controller to learn about their contents and origin, to verify their accuracy or to ask for them to be supplemented, cancelled, updated or corrected, or for their transformation into anonymous format or to block any data held in violation of the law, as well as to oppose their treatment for all legitimate reasons. Requests should be sent to the Data Controller at the contact information set out above.

Right to Lodge a Complaint

Under Article 77 of GDPR, as a data subject, you have the right to lodge a complaint with a supervisory authority. In Ireland the supervisory authority is the Office of the Data Commissioner.

Changes to this privacy policy

The Data Controller reserves the right to make changes to this privacy policy at any time by giving notice to its users on this page. It is strongly recommended to check this page often, referring to the date of the last modification listed at the bottom. If a user objects to any of the changes to the policy, the user must cease using this Application and can request that the Data Controller remove the personal data. Unless stated otherwise, the then-current privacy policy applies to all personal data the Data Controller has about users.

Contact

All questions, comments and requests regarding this Privacy Policy should be addressed to sales@compuscript.com.